Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine

Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine

Vaccines preventing tuberculosis disease progression have shown promising results in recent trials. Here, the authors use mathematical modelling to estimate that this type of vaccine could avert 10% of cases of rifampicin-resistant tuberculosis and 7% of deaths from 2020-2035.

Guardado en:
Detalles Bibliográficos
Autores principales: Han Fu, Joseph A. Lewnard, Isabel Frost, Ramanan Laxminarayan, Nimalan Arinaminpathy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/8295a488396e416da2b87fee41569db6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares